Discontinuation report FLUZONE HIGH-DOSE

Last updated on 2021-03-11 History
Report ID 134564
Drug Identification Number 02445646
Brand name FLUZONE HIGH-DOSE
Common or Proper name Influenza Virus Vaccine Trivalent Types A and B (Split Virion)
Company Name SANOFI PASTEUR LIMITED
Market Status CANCELLED POST MARKET
Active Ingredient(s) HAEMAGGLUTININ-STRAIN A HAEMAGGLUTININ-STRAIN A HAEMAGGLUTININ-STRAIN B
Strength(s) 60MCG 60MCG 60MCG
Dosage form(s) SUSPENSION SUSPENSION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 10 x 0.5 mL (single dose) syringes without attached needle
ATC code J07BB
ATC description VIRAL VACCINES
Reason for discontinuation Business reasons
Anticipated discontinuation date 2020-11-06
Actual discontinuation date 2020-11-06
Remaining supply date 2020-11-20
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments Sanofi Pasteur Limited is launching Fluzone® High-Dose Quadrivalent for 2021/22 influenza season. FLUZONE Fluzone® High-Dose Trivalent has been discontinued.
Health Canada comments
Contact Address 1755 STEELES AVENUE WEST
TORONTO, ONTARIO
CANADA M2R 3T4
Company contact information Customer Service/Service à la clientèle: 416-667-2611 or 1-800-268-4171 Vaccine Information Service/Service d'information sur les vaccins: 416-667-2779 or 1-888-621-1146

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2021-03-11 French Compare
v3 2021-03-11 English Compare
v2 2021-02-22 French Compare
v1 2021-02-22 English Compare